Home > Boards > US OTC > Cannabis > Easton Pharmaceuticals, Inc. (EAPH)

to Rule 15c2-11. This pertains to eaph since

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
starkd748 Member Profile
Member Level 
Followed By 437
Posts 34,888
Boards Moderated 3
Alias Born 04/28/13
160x600 placeholder
starkd748 Member Level  Wednesday, 09/30/20 09:19:02 PM
Re: R-Ray post# 75744
Post # of 75794 
to Rule 15c2-11. This pertains to eaph since they are Dark.

https://www.sec.gov/news/press-release/2020-212

“The amended rule represents another important step in our tireless and proactive efforts to protect retail investors from being victimized by microcap fraud”

The rule enhances disclosures and investor protection in the OTC:

“by ensuring that broker-dealers, in their role as professional gatekeepers to this market, do not publish quotations for an issuer’s security when current issuer information is not publicly available, subject to certain exceptions”.

The Final Rule in full:

https://www.sec.gov/rules/final/2020/33-10842.pdf


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences